Literature DB >> 17302379

Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.

Isabelle Heard1, Valérie Potard, Dominique Costagliola.   

Abstract

BACKGROUND: Although highly active antiretroviral therapy (HAART) has lowered the incidence of various opportunistic diseases, its impact on cervical squamous intraepithelial lesions (SILs) is unclear. Our objective was to compare the incidence of SILs in HIV-infected women receiving HAART versus those not receiving HAART and to determine the role of risk factors including immunosuppression in the pathogenesis of SIL.
METHODS: A total of 298 HIV-infected women with normal Papanicolaou (Pap) smear and normal colposcopic findings at enrollment were followed-up until incident SIL or last follow-up visit. Cox regression modelling was used to assess risks factors for incident SIL.
RESULTS: Eighty-eight women developed SILs, including 75 low-grade lesions, during a median follow-up of 28 months (16-52; incidence of 8.7 cases per 100 person-years). No invasive cervical cancers were identified. Incidence decreased from 10.7 to 6.5 per 100 person-years in non-receiving versus receiving HAART women (relative risk [RR]: 0.7; 95% confidence interval [CI]: 0.4-1.2, P=0.15, from the adjusted Cox model). Incident SIL was not associated to low CD4+ T-cell count (P=0.54). In multivariate analysis, the only significant risk factor for incident lesion was the age between 30-39 compared with over 40 (RR: 3.5; 95% CI: 1.4-8.9; P=0.02).
CONCLUSION: No impact in the development of SIL was evidenced for CD4+ T-cell counts, but we cannot exclude a modest impact of HAART. All HIV-positive women should be offered to participate in cervical cancer screening programmes whether or not they receive effective antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17302379

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  11 in total

1.  An unmet cancer screening need of HIV-positive women in southeastern Nigeria.

Authors:  Cyril C Dim; Ngozi R Dim; Hyginus U Ezegwui; Arthur C Ikeme
Journal:  Medscape J Med       Date:  2009-01-20

2.  HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.

Authors:  Gui Liu; Monisha Sharma; Nicholas Tan; Ruanne V Barnabas
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

3.  Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.

Authors:  Megan J Huchko; Hannah Leslie; Jennifer Sneden; May Maloba; Naila Abdulrahim; Elizabeth A Bukusi; Craig R Cohen
Journal:  Int J Cancer       Date:  2013-09-13       Impact factor: 7.396

4.  Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART.

Authors:  David H Adler; Lisa Kakinami; Tebogo Modisenyane; Nkeko Tshabangu; Lerato Mohapi; Guy De Bruyn; Neil A Martinson; Tanvier Omar
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

Review 5.  The impact of HAART on HPV-related cervical disease.

Authors:  David H Adler
Journal:  Curr HIV Res       Date:  2010-10       Impact factor: 1.581

Review 6.  Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities.

Authors:  Lilian Makgoo; Salerwe Mosebi; Zukile Mbita
Journal:  Front Mol Biosci       Date:  2022-05-10

7.  The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research.

Authors:  Lara F Bratcher; Vikrant V Sahasrabuddhe
Journal:  Infect Agent Cancer       Date:  2010-05-12       Impact factor: 2.965

8.  The impact of human immunodeficiency virus infection on cervical preinvasive and invasive neoplasia in South Africa.

Authors:  Louis-Jacques van Bogaert
Journal:  Ecancermedicalscience       Date:  2013-07-23

9.  Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.

Authors:  Anne F Rositch; Patti E Gravitt; Aaron A R Tobian; Kevin Newell; Thomas C Quinn; David Serwadda; Paschal Ssebbowa; Valerian Kiggundu; Ronald H Gray; Steven J Reynolds
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

Review 10.  Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.

Authors:  Helen Kelly; Helen A Weiss; Yolanda Benavente; Silvia de Sanjose; Philippe Mayaud
Journal:  Lancet HIV       Date:  2017-10-26       Impact factor: 12.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.